 - Prior androgen deprivation therapy andor first generation anti-androgen e.g. bicalutamide, nilutamide, flutamide for biochemically recurrent prostate cancer. Prior ADT andor first generation anti-androgen in the neoadjuvant andor salvage setting before, during, andor following radiation or surgery is allowed provided last effective dose of ADT andor first-generation anti-androgen is 9 months prior to date of randomization and total duration of prior therapy is 36 months. 